This protocol addresses patients presenting with tympanic membrane perforation who also have concurrent sensorineural hearing loss (SNHL). The coexistence of these two conditions defines a specific clinical sub-population requiring targeted management distinct from uncomplicated perforation alone.
Sensorineural hearing loss with tympanic membrane perforation — a scenario in which inner-ear or auditory-nerve pathology accompanies the structural disruption of the tympanic membrane, raising distinct therapeutic priorities.
For SNHL with TMP treat with high dose weaning regimen oral prednisolone as per SSNHL Clinical Practice Guideline.